<< Back to News

System Formulary Update
Glofitamab-gxbm (Columvi)

Situation:

Glofitamab-gxbm (Columvi) 2.5 mg/2.5 mL (1 mg/mL) SDV & 10 mg/10 mL (1 mg/mL) SDV for injection were approved for addition to the health system formulary at the September 2023 System Pharmacy and Therapeutics Committee meeting.

Background:

The following medication was reviewed: Glofitamab-gxbm (Columvi) 2.5 mg/2.5 mL (1 mg/mL) SDV & 10 mg/10 mL (1 mg/mL) SDV for injection

Assessment/Recommendations:

System P&T voted to include the following product from the UNC Health Medication Formulary:

• Glofitamab-gxbm (Columvi) 2.5 mg/2.5 mL (1 mg/mL) SDV & 10 mg/10 mL (1 mg/mL) SDV for injection

Note: Stock of this formulary product may vary at individual entities 

Formulary/Epic Changes will Go-Live on Tuesday, October 24, 2023